Special NoticePosted Sep 14, 2026·Responses due Sep 17, 2026

GSLDS Program Monitoring and Evaluation Support Services

CDC · CENTERS FOR DISEASE CONTROL AND PREVENTION

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
Not stated
Value
Not stated
Solicitation
75D30126Q79285
Set-aside
None stated
PSC
Not stated
Place
Atlanta, GA, USA
Contact
David Eccleston (upx5@cdc.gov)
…Open on SAM.gov
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75D30126Q79285 in this department, oldest first.

Early notice
  • Sep 14, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (2 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to contractor�s Peraton Inc. The purpose of this requirement is to obtain contractor support to provide program monitoring and evaluation services for GSLDS programs and operations. The contractor shall provide subject matter expertise, analytic support, technical assistance, and perform a broad range of services to support GSLDS monitoring and evaluation activities and program and operations. These services include supporting the ongoing implementation related to prevention, detection… (show all)

, and response capabilities associated with global health security programs.. Insert the capability required that makes it a sole source. This contract action is for supplies and/or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.101(b). See note below This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 3 of days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email UPX5@cdc.gov by Noon September 17, 2026.

Who won similar work

111 award notices on SAM.gov in the last 24 months. Matched by: Same agency (CDC), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

Single-winner award sizes (111): middle half $247K to $9.0M, median $992K; range $14K to $4.5B.

WinnerAwardsValueLast
POLOLEI SOLUTIONS, LLC5$3.3MJul 21, 2026
GLAXOSMITHKLINE, LLC3$1.7BMar 27, 2026
RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA3$9.8MJun 4, 2026
MERCK SHARP & DOHME LLC · $MRK · $60.1B2$4.5BSep 14, 2026
Pfizer New York NY 10001 USA2$1.2BJun 3, 2026
SEQIRUS USA INC2$663.9MDec 31, 2024
Moderna Princeton NJ 08540 USA2$314.2MJun 3, 2026
SANOFI PASTEUR INC.2$233.3MDec 31, 2024
AMERICAN TYPE CULTURE COLLECTION Manassas VA 20110 USA2$155.3MMay 18, 2026
ASTRAZENECA PHARMACEUTICALS LP2$61.0MDec 31, 2024

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $MRK reported $60.1B revenue in FY2025. The median single-winner award in these 111 past awards, $992K, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (4 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • $99K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 7 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.